You can buy or sell Sunesis and other stocks, options, ETFs, and crypto commission-free!
Sunesis Pharmaceuticals, Inc. engages in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. The firm's activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. Read More The company was founded on February 10, 1998 and is headquartered in South San Francisco, CA.
South San Francisco, California
52 Week High
52 Week Low
— per share
Expected May 7, After Hours